Substandard and falsified medicines are a global health threat. The fight against them is a regulatory and research challenge; here, the authors argue the importance of global and regional oversight, monitoring of, and research into the extent of the issue.
- Fanqi Zeng
- Simon Mariwah
- Heather Hamill